PHARMACIE RIBES : revenue, balance sheet and financial ratios

PHARMACIE RIBES is a French company founded 35 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in THUIR (66300), this company of category PME shows in 2025 a revenue of 4.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE RIBES (SIREN 378402713)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 4 573 437 € N/C N/C N/C N/C N/C 2 928 732 € 2 664 825 € 2 574 881 € 2 435 588 €
Net income 227 355 € 219 045 € 218 641 € 246 763 € 160 391 € 135 044 € 144 510 € 167 405 € 150 445 € 119 934 €
EBITDA 312 428 € N/C N/C N/C N/C N/C 151 887 € 162 372 € 141 661 € 129 275 €
Net margin 5.0% N/C N/C N/C N/C N/C 4.9% 6.3% 5.8% 4.9%

Revenue and income statement

En 2025, PHARMACIE RIBES alcanza unos ingresos de 4.6 M€. En el período 2016-2025, la empresa muestra un fuerte crecimiento con una TCAC de +7.3%. Tras deducir el consumo (3.4 M€), el margen bruto se sitúa en 1.1 M€, es decir, una tasa del 25%. El EBITDA alcanza 312 k€, representando el 6.8% de los ingresos. El margen operativo sigue siendo frágil, requiriendo vigilancia de costes. El resultado neto asciende a 227 k€, es decir, el 5.0% de los ingresos.

Revenue (2025) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

4 573 437 €

Gross margin (2025) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

1 136 924 €

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

312 428 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

291 315 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

227 355 €

EBITDA margin (2025) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

6.8%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 4%. Este nivel muy bajo refleja una estructura financiera sólida. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 67%. Esta alta autonomía significa que la empresa financia la mayoría de sus activos con fondos propios. La capacidad de reembolso indica que se necesitarían 0.3 años de flujo de caja. Este corto período demuestra una excelente sostenibilidad de la deuda. El flujo de caja representa el 5.2% de los ingresos. Nivel satisfactorio que permite financiar parcialmente el crecimiento.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

4.379%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

66.846%

Cash flow / Revenue (2025) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

5.25%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.264

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

25.2%

Solvency indicators evolution
PHARMACIE RIBES

Sector positioning

Ratio de endeudamiento
4.38 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Excelente

En 2025, el ratio de endeudamiento de PHARMACIE RIBES (4.38) se sitúa en el 25% más bajo del sector, lo cual es positivo. Este ratio mide el peso de la deuda en relación con el patrimonio. Un ratio bajo indica una estructura financiera sólida con poca dependencia de los acreedores.

Autonomía financiera
66.85% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Bueno -7 pts over 3 years

En 2025, el autonomía financiera de PHARMACIE RIBES (66.8%) se sitúa por encima de la mediana del sector. Este ratio representa la parte del patrimonio en la financiación total. Esta posición cómoda ofrece un margen de seguridad apreciable.

Capacidad de reembolso
0.26 ans 2025
2025
Q1: 0.51 ans
Med: 2.46 ans
Q3: 6.17 ans
Excelente

En 2025, el capacidad de reembolso de PHARMACIE RIBES (0.3 an) se sitúa en el 25% más bajo del sector, lo cual es positivo. Este ratio indica el número de años necesarios para pagar la deuda con flujo de caja. Una capacidad corta refleja deuda controlada y buena generación de efectivo.

Liquidity ratios

El ratio de liquidez se sitúa en 197.48. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

197.484

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
PHARMACIE RIBES

Sector positioning

Ratio de liquidez
197.48 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Bueno +7 pts over 3 years

En 2025, el ratio de liquidez de PHARMACIE RIBES (197.48) se sitúa por encima de la mediana del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Esta posición cómoda ofrece un margen de seguridad apreciable.

Cobertura de intereses
0.0x 2025
2025
Q1: 0.0x
Med: 1.91x
Q3: 5.98x
Average

En 2025, el cobertura de intereses de PHARMACIE RIBES (0.0x) se sitúa por debajo de la mediana del sector. Este ratio indica cuántas veces el resultado operativo cubre los gastos de intereses. Una mejora fortalecería la posición competitiva.

Working capital requirement (WCR) and payment terms

El fondo de maniobra operativo (FM) mide el desfase temporal de tesorería. Plazo medio de cobro a clientes: 5 días. Plazo proveedores: 54 días. Excelente situación: los proveedores financian 49 días del ciclo operativo. La rotación de existencias es de 25 días. Rotación rápida, señal de buena gestión de existencias. El FM representa 40 días de ingresos. En 2016-2025, el FM aumentó en +30%.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

510 899 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

5 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

54 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

25 j

WCR in days of revenue (2025) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

40 j

WCR and payment terms evolution
PHARMACIE RIBES

Positioning of PHARMACIE RIBES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE RIBES is estimated at 2 760 923 € (range 1 711 739€ - 3 849 461€). With an EBITDA of 312 428€, the sector multiple of 7.7x is applied. The price/revenue ratio is 0.61x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1711k€ 2760k€ 3849k€
2 760 923 € Range: 1 711 739€ - 3 849 461€
NAF 5 année 2025

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
312 428 € × 7.7x
Estimation 2 412 039 €
1 216 381€ - 3 511 425€
Revenue Multiple 30%
4 573 437 € × 0.61x
Estimation 2 775 307 €
2 044 615€ - 3 201 138€
Net Income Multiple 20%
227 355 € × 15.9x
Estimation 3 611 561 €
2 450 822€ - 5 667 037€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE RIBES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE RIBES

What is the revenue of PHARMACIE RIBES ?

The revenue of PHARMACIE RIBES in 2025 is 4.6 M€.

Is PHARMACIE RIBES profitable?

Yes, PHARMACIE RIBES generated a net profit of 227 k€ in 2025.

Where is the headquarters of PHARMACIE RIBES ?

The headquarters of PHARMACIE RIBES is located in THUIR (66300), in the department Pyrenees-Orientales.

Where to find the tax return of PHARMACIE RIBES ?

The tax return of PHARMACIE RIBES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE RIBES operate?

PHARMACIE RIBES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.